A delayed clinical trial actually boosted Bristol Myers Squibb’s stock.
Here’s why.
-
Bristol Myers’ stock rallied Wednesday as investors maintained high hopes
for Cobenfy as an Alzheimer’s treatment, even though the outcome of a
late-stage ...
35 minutes ago





The president used his weekly radio and Internet address Saturday to try to position himself on the side of the public and against a Congress with abysmal approval ratings in the wake of the bitter partisan bickering over the debt.
ReplyDeleteObama's approval ratings aren't so good either, but the president clearly sees a need to direct the public's anger at Washington toward lawmakers in Congress – or risk being its target himself as the 2012 presidential campaign season opens.